Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-05-01

DOI:

10.1073/pnas.2502978122

Affiliations:

12

Authors:

21

Go to article

Institutions	Authors	Share
Yale University, United States of America (USA)	12.000000 12.000000	0.57
Chiba University, Japan	2.500000	0.12
German Diabetes Center - Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf (DDZ), Germany	1.666667	0.08
German Center for Diabetes Research (DZD), Germany	1.666667	0.08
Kazusa DNA Research Institute (KDRI), Japan	1.000000	0.05
Ionis Pharmaceuticals, United States of America (USA)	1.000000	0.05
University Hospital Duesseldorf (UKD), Germany	0.666667	0.03
VA Connecticut Healthcare System, United States of America (USA)	0.500000	0.02
Howard Hughes Medical Institute (HHMI), United States of America (USA)	0.000000	0.00

Interested in Medical Biochemistry and Metabolomics?